ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,399Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 663

$496K Total Retail Price of All Prescriptions

Rank: 67 out of 663

234 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 234 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

18% of this provider’s 234 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 9,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 495 472 1 3
WARFARIN SODIUM 473 438 2 8
FUROSEMIDE 436 383 3 7
LISINOPRIL 383 376 4 2
CITALOPRAM HBR 374 343 5 18
METOPROLOL TARTRATE 357 334 6 11
POTASSIUM CHLORIDE 272 244 7 23
AMLODIPINE BESYLATE 253 238 8 5
GABAPENTIN 244 209 9 20
SIMVASTATIN 204 183 10 1
LIDODERM 200 177 11 67
HYDROCODONE-ACETAMINOPHEN 180 157 S3 12 6
DONEPEZIL HCL 175 160 13 40
TRAMADOL HCL 164 155 14 17
CYMBALTA 137 85 15 54
QUETIAPINE FUMARATE 132 128 16 69
OMEPRAZOLE 128 100 17 4
LANTUS 123 102 18 48
OXYCODONE-ACETAMINOPHEN 120 113 S2 19 26
OXYBUTYNIN CHLORIDE 111 96 20 99
RANITIDINE HCL 107 104 21 31
NAMENDA 100 100 22 57
MIRTAZAPINE 95 78 23 52
ATORVASTATIN CALCIUM 93 91 24 13
IPRATROPIUM-ALBUTEROL 92 89 25 108
MORPHINE SULFATE ER 90 43 S2 26 51
ATENOLOL 89 89 27 10
LEVETIRACETAM 85 73 28 123
ONDANSETRON HCL 83 75 29 250
FAMOTIDINE 81 81 30 76
CARVEDILOL 79 71 31 47
DIVALPROEX SODIUM 76 69 32 81
AMIODARONE HCL 76 76 32 278
ENOXAPARIN SODIUM 74 55 34 281
POLYETHYLENE GLYCOL 3350 73 66 35 82
SEROQUEL 68 54 36 176
ESCITALOPRAM OXALATE 67 67 37 77
LATANOPROST 67 67 37 157
BACLOFEN 63 47 39 122
TRAZODONE HCL 62 47 40 34
LEVOFLOXACIN 62 58 40 92
SPIRIVA 62 62 40 62
OLANZAPINE 61 50 43 88
DIOVAN 57 57 44 59
PREDNISONE 57 37 44 39
SERTRALINE HCL 57 50 44 35
CLOPIDOGREL 56 56 47 65
NYSTATIN 56 50 47 124
LACTULOSE 55 15 49 111
ZOLPIDEM TARTRATE 54 41 50 16
CIPROFLOXACIN HCL 53 51 51 74
METFORMIN HCL 53 48 51 9
VANCOMYCIN HCL 52 44 53 174
SPIRONOLACTONE 52 48 53 58
GLIPIZIDE 51 44 55 29
DIGOXIN 51 51 55 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.